Early Chemotherapy Intensification With BEACOPP in High-Risk, Interim-PET Positive Advanced-Stage Hodgkin Lymphoma:a GITIL Retrospective Multicenter Clinical Study
Observational
Observational Model: Cohort, Time Perspective: Retrospective
Progression Free Survival
2 years
No
Andrea Gallamini, MD
Principal Investigator
Azienda Ospedaliera Santa Croce e Carle
Italy: Ethics Committee
HD-PET-intens-retr
NCT00877747
January 2006
September 2009
Name | Location |
---|